Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.12
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.